DURECT CORP stock forecast: up to 0.94 USD DRRX stock price prognosis


Forecast for Fri 28 Jan 2022 price 1.54

DURECT CORP stock price forecast for further price development up to 4.45% (time horizon: 1 day) and price target of 0.94 USD. Positive news sentiment. Short-term (time horizon: 2 weeks) DURECT CORP share price prediction for 2022-01-28 with daily closed price projections

Key Facts

Symbol DRRX 

ISIN US2666051048 

CUSIP 266605104

Currency USD

Category Pharmaceutical Preparations

Forecast price change %

News sentiment (0.25)

Finance numbers

Revenue 31,919,000.0

Earnings per share -0.02

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.

Summerized Form 10-K with GPT-2

DUR-928 is also being investigated in patients with nonalcoholic steatohepatitis (NASH). 89% of the overall DUR-928 patient population were treatment responders based on Lille. We may report additional efficacy signals of this trial at a future medical conference. Indivior commercially launched PERSERIS in the U.S. in February 2019. Diversify Risk by Pursuing Multiple Programs in Development. This license includes rights to nine patent families. There can be no assurance that the pending patent applications will be granted. In the United States, POSIMIR is covered by four patent families. These efforts by us may not be successful. Our submission of an IND may not result in FDA authorization to commence clinical trials. These entities represent significant competition for us. Our Code of Ethics can be found on our website. Norman L. Sussman, M.D., FAASLD, joined DURECT as Chief Medical Officer in November 2020. We are currently developing DUR-928 in several indications, including AH and NASH. We cannot predict how successful we will be at enrolling patients in our clinical trials. Indivior has stated that it launched PERSERIS in February 2019 in the United States. Any of our present or future collaborators may not perform their obligations as expected. It also initiated the imposition of tariffs on certain foreign products.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/1082038/000156459021011240/0001564590-21-011240.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 30.00/100

Institutional ownership list is based on filling form information

Holding name Date Amount
Engineers Gate Manager LP 2021-03-31 24835

Fund ownership list is based on filling form information

Fund name Date Amount Profile
Fidelity Concord Street Trust 2021-05-31 300972 Long
Fidelity Salem Street Trust 2021-04-30 1660263 Long
Fidelity Concord Street Trust 2021-04-30 42314 Long
FIDELITY COVINGTON TRUST 2021-04-30 92470 Long
iShares Trust 2021-04-30 82437 Long

Insider trading for DURECT CORP

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1604753 Joice Judy R 2021-05-14 SALE Accept 0 0 0

DURECT CORP Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

On-Balance Volume information for DURECT CORP. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for DURECT CORP. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for DURECT CORP. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for DURECT CORP. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for DURECT CORP. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for DURECT CORP. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for DURECT CORP. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares


DURECT CORP on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2021-12-06 0.94 2021-12-04 05:23
2021-12-07 0.96 2021-12-04 05:23
2021-12-08 1.00 2021-12-04 05:23
2021-12-09 1.02 2021-12-04 05:23
2021-12-10 1.04 2021-12-04 05:23
2021-12-13 1.07 2021-12-04 05:23
2021-12-14 1.09 2021-12-04 05:23
2021-12-15 1.11 2021-12-04 05:23
2021-12-16 1.13 2021-12-04 05:23
2021-12-17 1.14 2021-12-04 05:23
2021-12-20 1.16 2021-12-04 05:23
2021-12-21 1.18 2021-12-04 05:23
2021-12-22 1.20 2021-12-04 05:23
2021-12-23 1.21 2021-12-04 05:23
2021-12-24 1.23 2021-12-04 05:23
2021-12-27 1.25 2021-12-04 05:23
2021-12-28 1.27 2021-12-04 05:23
2021-12-29 1.28 2021-12-04 05:23
2021-12-30 1.30 2021-12-04 05:23
2021-12-31 1.31 2021-12-04 05:23
2022-01-05 1.36 2021-12-04 05:23
2022-01-06 1.37 2021-12-04 05:23
2022-01-07 1.38 2021-12-04 05:23
2022-01-03 1.33 2021-12-04 05:23
2022-01-04 1.34 2021-12-04 05:23
2022-01-10 1.40 2021-12-04 05:23
2022-01-11 1.41 2021-12-04 05:23
2022-01-12 1.42 2021-12-04 05:23
2022-01-13 1.43 2021-12-04 05:23
2022-01-14 1.44 2021-12-04 05:23
2022-01-17 1.46 2021-12-04 05:23
2022-01-18 1.47 2021-12-04 05:23
2022-01-19 1.48 2021-12-04 05:23
2022-01-20 1.49 2021-12-04 05:23
2022-01-21 1.50 2021-12-04 05:23
2022-01-24 1.51 2021-12-04 05:23
2022-01-25 1.52 2021-12-04 05:23
2022-01-26 1.53 2021-12-04 05:23
2022-01-27 1.53 2021-12-04 05:23
2022-01-28 1.54 2021-12-04 05:23